コンテンツへスキップ
Merck

Patterns of genome evolution that have accompanied host adaptation in Salmonella.

Proceedings of the National Academy of Sciences of the United States of America (2014-12-24)
Gemma C Langridge, Maria Fookes, Thomas R Connor, Theresa Feltwell, Nicholas Feasey, Bryony N Parsons, Helena M B Seth-Smith, Lars Barquist, Anna Stedman, Tom Humphrey, Paul Wigley, Sarah E Peters, Duncan J Maskell, Jukka Corander, Jose A Chabalgoity, Paul Barrow, Julian Parkhill, Gordon Dougan, Nicholas R Thomson
要旨

Many bacterial pathogens are specialized, infecting one or few hosts, and this is often associated with more acute disease presentation. Specific genomes show markers of this specialization, which often reflect a balance between gene acquisition and functional gene loss. Within Salmonella enterica subspecies enterica, a single lineage exists that includes human and animal pathogens adapted to cause infection in different hosts, including S. enterica serovar Enteritidis (multiple hosts), S. Gallinarum (birds), and S. Dublin (cattle). This provides an excellent evolutionary context in which differences between these pathogen genomes can be related to host range. Genome sequences were obtained from ∼ 60 isolates selected to represent the known diversity of this lineage. Examination and comparison of the clades within the phylogeny of this lineage revealed signs of host restriction as well as evolutionary events that mark a path to host generalism. We have identified the nature and order of events for both evolutionary trajectories. The impact of functional gene loss was predicted based upon position within metabolic pathways and confirmed with phenotyping assays. The structure of S. Enteritidis is more complex than previously known, as a second clade of S. Enteritidis was revealed that is distinct from those commonly seen to cause disease in humans or animals, and that is more closely related to S. Gallinarum. Isolates from this second clade were tested in a chick model of infection and exhibited a reduced colonization phenotype, which we postulate represents an intermediate stage in pathogen-host adaptation.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
プロピレングリコール, ≥99.5% (GC), FCC, FG
Sigma-Aldrich
エタノールアミン, ≥99%
Sigma-Aldrich
エタノールアミン, purified by redistillation, ≥99.5%
USP
プロピレングリコール, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
エタノールアミン, ≥98%
Sigma-Aldrich
1,2-プロパンジオール, ACS reagent, ≥99.5%
Sigma-Aldrich
Propylene Glycol, meets USP testing specifications
Sigma-Aldrich
エタノールアミン, ACS reagent, ≥99.0%
Supelco
プロピレングリコール, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
1,2-プロパンジオール, ReagentPlus®, 99%
Sigma-Aldrich
エタノールアミン, liquid, BioReagent, suitable for cell culture, ≥98%
Sigma-Aldrich
1,2-プロパンジオール, puriss. p.a., ACS reagent, ≥99.5% (GC)
Supelco
1,2-プロパンジオール, analytical standard
Sigma-Aldrich
1,2-プロパンジオール, meets analytical specification of Ph. Eur., BP, USP, ≥99.5%
Sigma-Aldrich
エタノールアミン, JIS special grade, ≥99.0%
Supelco
エタノールアミン, analytical standard
プロピレングリコール, European Pharmacopoeia (EP) Reference Standard
Supelco
アウクビン, analytical standard
Sigma-Aldrich
1,2-プロパンジオール, SAJ special grade, ≥99.0%
Sigma-Aldrich
エタノールアミン, puriss. p.a., ACS reagent, ≥99.0% (GC/NT)
Sigma-Aldrich
1,2-プロパンジオール, SAJ first grade, ≥99.0%
Sigma-Aldrich
1,2-プロパンジオール, tested according to Ph. Eur.
エタノールアミン, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
エタノールアミン, SAJ first grade, ≥99.0%
アウクビン, primary reference standard